---
title: "INDP.US (INDP.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/INDP.US/news.md"
symbol: "INDP.US"
name: "INDP.US"
parent: "https://longbridge.com/en/quote/INDP.US.md"
datetime: "2026-05-20T22:24:41.731Z"
locales:
  - [en](https://longbridge.com/en/quote/INDP.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/INDP.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/INDP.US/news.md)
---

# INDP.US (INDP.US) — Related News

### [Indaptus Therapeutics Q1 net loss narrows, cash reserves decline significantly](https://longbridge.com/en/news/286590457.md)
*2026-05-15T15:49:09.000Z*
> Indaptus Therapeutics announced its Q1 2026 financial report, with a net loss of $2.54 million, significantly narrowing 

### [Indaptus Therapeutics | 10-Q: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286563723.md)
*2026-05-15T12:18:05.000Z*
### [Indaptus Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286561288.md)
*2026-05-15T12:02:30.000Z*
### [Earnings Scheduled For May 15, 2026](https://longbridge.com/en/news/286557069.md)
*2026-05-15T11:11:24.000Z*
> On May 15, 2026, several companies are set to report their first-quarter earnings. Notable reports include Traws Pharma,

### [Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update | INDP Stock News](https://longbridge.com/en/news/286556778.md)
*2026-05-15T03:00:00.000Z*
> Indaptus Therapeutics reported its Q1 2026 financial results, showing a net loss of $2.5 million, down from $4.5 million

### [12 Health Care Stocks Moving In Friday's Pre-Market Session](https://longbridge.com/en/news/284897248.md)
*2026-05-01T12:05:59.000Z*
> In Friday's pre-market session, Cue Biopharma saw a significant gain of 90.1%, reaching $28.02, while Esperion Therapeut

### [Indaptus Therapeutics names Tim Ruan and Yi Zhang as independent directors; Matthew McMurdo resigns](https://longbridge.com/en/news/283808882.md)
*2026-04-23T10:13:01.000Z*
> Indaptus Therapeutics has appointed Tim Ruan and Yi Zhang as independent directors, effective April 22, 2026, while Matt